Session: The paradox of non-adherence in symptomatic disease -
Skip to content
Home > Congress > Session > Session: The paradox of non-adherence in symptomatic disease

The paradox of non-adherence in symptomatic disease

Though it’s easy to grasp why asymptomatic patients may be non-adherent, healthcare providers may be perplexed by non-adherence in patients who suffer from unpleasant symptoms. A 2021 study found that 45% of such patients were taking insufficient doses of their treatment despite experiencing symptoms ranging from irritating to incapacitating. “Adherence often goes unrecognized. We think our patients follow our excellent healthcare advice,” said Dr. Sheri Pruitt, adding: “Patients tend to exaggerate what they tell us. They want to please us, they want our approval, they want us to think they are doing what we asked them to do.” Improving adherence starts with healthcare providers, who can change the way they communicate with patients to include open-ended questions, empathic responses, and a promise of a provider-patient partnership. For more insights from Prof. Löhr and Dr. Pruitt, please watch the video below.


Speakers

Prof. Matthias
Löhr

Sweden

Prof. Sheri
Pruitt

United States of America

Share this post

Read more on this topic

Session: Panel discussion - Sharing reflections and best practice

Session: Congress introduction second day

Session: Panel discussion - Raising adherence as a public health priority

Session: Closing congress first day

Session: Patient perspectives of adherence and how these can help us improve…

Session: International Society of Hypertension - Raising awareness on…

Session: International Society of Gynecological Endocrinology - From treating…

Session: Closing congress

Session: Practical individual interventions any healthcare professionals can…

Session: The challenge and causes of non-adherence

Session: Consequences of non-adherence to narrow therapeutic index drugs

Session: The paradox of non-adherence to treatment in oncology